HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christopher R Flowers Selected Research
Christopher R Flowers Research Topics
Disease
68
Neoplasms (Cancer)
04/2024 - 06/2007
41
Lymphoma (Lymphomas)
04/2024 - 06/2007
39
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2024 - 12/2010
36
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2024 - 06/2007
22
Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2024 - 09/2005
22
B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 02/2010
13
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2023 - 10/2013
11
Hodgkin Disease (Hodgkin's Disease)
01/2021 - 09/2005
9
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 09/2013
8
Multiple Myeloma
01/2019 - 10/2010
7
Hematologic Neoplasms (Hematological Malignancy)
10/2022 - 08/2011
6
Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 12/2014
5
Inflammation (Inflammations)
01/2023 - 11/2019
5
Leukemia
10/2018 - 01/2007
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2018 - 01/2007
4
Venous Thromboembolism
04/2024 - 01/2023
4
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2020 - 05/2015
4
Autoimmune Diseases (Autoimmune Disease)
01/2016 - 08/2014
3
Paralysis (Palsy)
04/2024 - 01/2023
3
Pulmonary Embolism
01/2023 - 06/2013
3
Venous Thrombosis (Deep-Vein Thrombosis)
01/2023 - 06/2013
3
Neutropenia
12/2022 - 03/2014
3
Disease Progression
02/2019 - 02/2016
3
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
07/2015 - 01/2011
2
Hemorrhage
01/2023 - 10/2020
2
Human Influenza (Influenza)
07/2021 - 01/2019
2
Peripheral Nervous System Diseases (PNS Diseases)
10/2020 - 11/2015
2
Fatigue
06/2020 - 10/2013
2
T-Cell Lymphoma (Lymphoma, T Cell)
11/2019 - 07/2015
2
Pneumonia (Pneumonitis)
10/2018 - 03/2014
2
Fever (Fevers)
10/2018 - 02/2013
Drug/Important Bio-Agent (IBA)
44
Rituximab (Mabthera)
FDA Link
05/2024 - 10/2009
17
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2024 - 04/2012
14
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2024 - 04/2012
13
Prednisone (Sone)
FDA Link
Generic
04/2024 - 07/2012
13
Vincristine (Oncovin)
FDA Link
Generic
11/2023 - 04/2012
12
Chimeric Antigen Receptors
IBA
01/2024 - 01/2018
8
ibrutinib
IBA
03/2024 - 01/2017
8
Vaccines
IBA
01/2022 - 06/2007
7
polatuzumab vedotin
IBA
05/2024 - 10/2020
6
Biomarkers (Surrogate Marker)
IBA
11/2022 - 01/2017
5
obinutuzumab
IBA
05/2024 - 01/2019
5
Anthracyclines
IBA
04/2024 - 01/2011
5
axicabtagene ciloleucel
IBA
11/2023 - 01/2021
5
Alkylating Agents
IBA
11/2023 - 09/2013
5
Lenalidomide (CC 5013)
FDA Link
11/2023 - 06/2020
5
Cytokines
IBA
01/2023 - 01/2018
5
Antigens
IBA
11/2019 - 07/2011
5
Bortezomib (Velcade)
FDA Link
11/2017 - 10/2009
4
Bendamustine Hydrochloride
FDA Link
09/2023 - 01/2017
4
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022 - 04/2012
4
idelalisib
IBA
01/2021 - 03/2014
4
Benzene (Benzole)
IBA
01/2020 - 09/2013
4
Etoposide (VP 16)
FDA Link
Generic
01/2016 - 08/2012
4
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
09/2013 - 08/2011
3
Monoclonal Antibodies
IBA
05/2024 - 09/2013
3
venetoclax
IBA
05/2024 - 01/2020
3
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 12/2012
3
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2023 - 01/2017
3
Antibodies
IBA
01/2023 - 06/2007
3
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2022 - 04/2012
3
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2022 - 02/2013
3
carboxyl radical (COO-)
IBA
01/2021 - 01/2019
3
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
10/2020 - 06/2013
3
Anticoagulants
IBA
10/2020 - 06/2013
3
Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)
IBA
11/2016 - 06/2007
3
Busulfan (Busulfex)
FDA Link
01/2016 - 08/2012
3
fludarabine
IBA
11/2015 - 05/2015
3
plerixafor
FDA Link
09/2013 - 10/2011
2
zanubrutinib
IBA
03/2024 - 11/2023
2
Biological Factors
IBA
01/2024 - 06/2020
2
Immune Checkpoint Inhibitors
IBA
01/2023 - 04/2017
2
Proteins (Proteins, Gene)
FDA Link
01/2023 - 11/2019
2
Interferons
IBA
01/2023 - 11/2020
2
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2022
2
apixaban
IBA
01/2023 - 10/2020
2
Rivaroxaban
IBA
01/2023 - 10/2020
2
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 04/2012
2
pembrolizumab
IBA
01/2022 - 04/2017
2
Influenza Vaccines (Influenza Vaccine)
FDA Link
07/2021 - 01/2019
2
Radium
IBA
01/2021 - 01/2021
2
ublituximab
IBA
11/2019 - 02/2019
2
umbralisib
IBA
11/2019 - 02/2019
2
Carcinogens
IBA
11/2019 - 04/2016
2
purine
IBA
10/2018 - 09/2013
2
Antiviral Agents (Antivirals)
IBA
10/2018 - 10/2011
2
Clindamycin (Cleocin)
FDA Link
Generic
10/2018 - 02/2013
Therapy/Procedure
90
Therapeutics
04/2024 - 01/2007
32
Drug Therapy (Chemotherapy)
01/2023 - 09/2005
13
Stem Cell Transplantation
01/2023 - 09/2005
7
Immunotherapy
01/2023 - 06/2007
6
Transplantation
10/2020 - 01/2007
5
Radiotherapy
01/2021 - 09/2005
4
Salvage Therapy
11/2017 - 12/2013
3
Precision Medicine
01/2020 - 06/2017
3
Hematopoietic Stem Cell Transplantation
10/2018 - 06/2014
3
Hematopoietic Stem Cell Mobilization
09/2013 - 08/2011
2
Injections
01/2023 - 01/2022
2
Combined Modality Therapy
01/2021 - 12/2016
2
Photopheresis
11/2020 - 11/2010